To further complicate clinicians’ treatment decisions, Padcev-Keytruda has become the new standard of care in first-line metastatic bladder cancer, raising the possibility that some physicians might ...
Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with ...
Preliminary results from a phase Ib study of neoadjuvant ipilimumab plus nivolumab prior to liver resection for hepatocellular carcinoma: The PRIME-HCC trial. This is an ASCO Meeting Abstract from the ...
MedPage Today on MSN
Padcev-Keytruda Combo Lands Another Win in Bladder Cancer
Regimen significantly improved survival over standard neoadjuvant chemotherapy ...
Study of late toxicities of chemotherapy regimens in testicular cancer survivors shows that higher cisplatin doses link renal impairment to increased heart health risks.
Please provide your email address to receive an email when new articles are posted on . Survival outcomes did not differ for patients with HNSCC who received radiotherapy with carboplatin-paclitaxel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results